HAL vs SLS · P/E 9.3, $19.05B cap vs $1.62B cap
Halliburton Company (HAL) versus Sellas Life Sciences Group Inc (SLS) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$9.6M. SLS currently screens at market cap $1.62B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. SLS currently screens at market cap $1.62B.
Not investment advice. Open the HAL and SLS stock pages for the full models.
Not investment advice.